Singapore will this week become the epicentre of latest global knowledge and advances in the treatment of infertility that affects an estimated one in six couples around the world.
The 2025 Congress of the Asia Pacific Initiative on Reproduction (ASPIRE), to be held at the Suntec Convention and Exhibition Centre from 1 to 4 May, will bring together experts from across the Asia Pacific region and beyond to lecture, learn and collaborate in the quest for optimum outcomes in reproductive science and medicine along with fertility nursing and counselling.
With over 2,000 delegates it will be one of the most influential meetings on fertility health ever presented in the Asia Pacific with outcomes that will empower the region and help shape the future of assisted conception throughout the world.
Infertility is defined as the failure to conceive after a year of unprotected intercourse, or the inability to carry pregnancies to a live birth. The causes of infertility are equally shared between male and female partners.
Countries around the world, and in the APAC region, are experiencing critical falls in total fertility rates that threaten population sustainability with major social and economic consequences.
While assisted reproduction technologies have been available for decades, with millions of children born worldwide from interventions such as in vitro fertilisation (IVF), equitable and affordable access to treatment is still limited in many parts of the world, particularly in low and middle-income countries.
According to the World Health Organisation, Government family-building policies can mitigate the many inequities in access to safe and effective fertility care.
ASPIRE President, Dr Clare Boothroyd, says humanity is entering uncharted territory in the phenomenon of depopulation, a crisis to be addressed at the Singapore Congress.
The Congress will feature an innovative and stimulating program offering keynote lectures, concurrent sessions, round table discussions and lively debates.
It will provide key insights into the future of IVF with advances in artificial intelligence and automation that can improve accessibility, affordability and success rates in fertility treatment.
Despite these innovations challenges remain to address issues of clinical validation and ethical oversight as artificial intelligence complements rather than replaces human-in-the-loop treatment expertise.
A major focus of the Congress will be on teaming together for evidence-based, patient-centred care including the psychosocial support of those trying to conceive.
To view the ASPIRE 2025 program and speakers, go to www.aspire2025.com
FURTHER INFORMATION – Trevor Gill, ASPIRE Congress Media Relations
Telephone: +61 418 821948 Email: lighthousepr@adelaide.on.net